Asthma study aims to unlock personalized treatments for chinese patients
NCT ID NCT06419413
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study is enrolling 355 adults with asthma in China to describe their clinical features, treatment patterns, and biological markers. Researchers will analyze lung function, imaging, and blood biomarkers to identify distinct asthma subtypes. The goal is to gather knowledge that could support the development of personalized treatment strategies for this population in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help identify asthma subtypes in Chinese patients, paving the way for more personalized treatment strategies in the future.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to other populations or lead to immediate changes in care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGChengdu, Sichuan, China
-
Research Site
NOT_YET_RECRUITINGBeijing, China
-
Research Site
NOT_YET_RECRUITINGChangsha, China
-
Research Site
NOT_YET_RECRUITINGDongguan, China
-
Research Site
NOT_YET_RECRUITINGFoshan, China
-
Research Site
NOT_YET_RECRUITINGGuangzhou, China
-
Research Site
NOT_YET_RECRUITINGHainan, China
-
Research Site
NOT_YET_RECRUITINGHohhot, China
-
Research Site
NOT_YET_RECRUITINGHuizhou, China
-
Research Site
NOT_YET_RECRUITINGKunming, China
-
Research Site
NOT_YET_RECRUITINGNanjing, China
-
Research Site
NOT_YET_RECRUITINGNanning, China
-
Research Site
NOT_YET_RECRUITINGShanghai, China
-
Research Site
NOT_YET_RECRUITINGShenyang, China
-
Research Site
RECRUITINGTaiyuan, China
-
Research Site
NOT_YET_RECRUITINGWenzhou, China
-
Research Site
RECRUITINGWuhan, China
-
Research Site
RECRUITINGXi'an, China
-
Research Site
NOT_YET_RECRUITINGXuzhou, China
-
Research Site
NOT_YET_RECRUITINGZhanjiang, China
-
Research Site
NOT_YET_RECRUITINGZhaoqing, China